Global and United States Intrauterine Contraceptive Device Market Insights, Forecast to 2027

An intrauterine contraceptive device is a medical device, which is inserted in the uterus to prevent conception. A plastic string is attached to the end of the device to ensure correct placement and its removal. This devices lasts for 5 to 8 years. These devices are available in various forms, such as coil, loop, triangle, and T-shaped, and are made up of plastic or metal.
Increasing prevalence of unplanned pregnancies, less side-effects associated with intrauterine contraceptive devices, and implementation of affordable care are some of the key factors driving the growth of the global intrauterine contraceptive device market. In addition, increasing awareness about pregnancy is also driving the growth of the global intrauterine contraceptive device market.

Market Analysis and Insights: Global and United States Intrauterine Contraceptive Device Market
This report focuses on global and United States Intrauterine Contraceptive Device market.
In 2020, the global Intrauterine Contraceptive Device market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In United States the Intrauterine Contraceptive Device market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Intrauterine Contraceptive Device Scope and Market Size
Intrauterine Contraceptive Device market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Intrauterine Contraceptive Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For United States market, this report focuses on the Intrauterine Contraceptive Device market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type
Hormonal IUCD
Copper IUCD

Segment by Application
Hospitals
Surgical Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Bayer HealthCare
Medisafe Distribution
Teva Pharmaceutical Industrie
Medicines360
Pace Pharmaceuticals